Similar to HSV-DTK depletion, mice-bearing tumors were radiated and administered with DT in 3 doses over the course of one week to ablate GEC/GPC (Supplementary Fig. 4g), resulting in significant inhibition in tumor growth (Supplementary Fig. 4h-j). The gene discussed is TYRO3; the disease is neoplasm.